Garo H. Armen - 13 Oct 2021 Form 3 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
/s/ Christine Klaskin, attorney-in-fact
Issuer symbol
INKT
Transactions as of
13 Oct 2021
Net transactions value
$0
Form type
3
Filing time
20 Oct 2021, 18:57:49 UTC
Previous filing
14 Sep 2021
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INKT Common Stock 2,226,400 13 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INKT Stock Option (Right to Buy) 13 Oct 2021 Common Stock 27,830 $0.0200 Direct F1
holding INKT Stock Option (Right to Buy) 13 Oct 2021 Common Stock 27,830 $0.0200 Direct F2
holding INKT Stock Option (Right to Buy) 13 Oct 2021 Common Stock 695,750 $0.0100 Direct F3
holding INKT Stock Option (Right to Buy) 13 Oct 2021 Common Stock 834,900 $3.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an option to purchase shares of the common stock, which vests as to 30% of the underlying shares on November 19, 2021 and as to the remaining 70% of the underlying shares on November 19, 2022, in each case, generally subject to continued employment.
F2 Represents an option to purchase shares of the common stock, which vests on or about December 31, 2022, as to a portion of the underlying shares as determined by the achievement of certain milestones between January 1, 2019 and December 31, 2022, with 20% vesting upon achievement of five milestones, and an additional 5% vesting for each.
F3 Represents an option to purchase shares of the common stock, which vested as to 33% of the underlying shares on January 30, 2021, and with respect to the remainder, in eight equal quarterly installments thereafter, in each case, generally subject to continued employment.
F4 Represents an option to purchase shares of the common stock, which vests as to 33% of the underlying shares on February 11, 2022, and with respect to the remainder, in eight equal quarterly installments thereafter, in each case, generally subject to continued employment.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney